PATRYS Ltd
PAB•Health Care•Biotechnology•Last updated: Dec 25
About
Patrys Ltd is an Australian biotechnology company focused on the development of antibody-based therapies for the treatment of cancer. The company is advancing its proprietary Deoxymab platform, which includes products such as PAT-DX1 and PAT-DX3, designed to target and penetrate cancer cells, disrupting their DNA repair mechanisms. Patrys aims to leverage its technology to develop novel treatments that enhance the effectiveness of existing cancer therapies.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- PAB
Related Shares
Investor Resources
Should you buy PATRYS Ltd right now?
While PAB looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now